Polar Capital’s Prothena Corp PRTA Stock Holding History

Polar Capital’s Portfolio PRTA Stock Details PRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-30,000	Closed	-$1.67M	–	261
2017 Q1	$1.67M	Buy	+30,000	New	+$1.58M	0.03%	237

Other funds holding PRTA

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Polar Capital's PRTA Position: Q2 2017 in Review

Polar Capital sold out of Prothena Corp (PRTA) in Q2 2017, closing a stake of 30,000 shares — an estimated $1.67M sold.

Polar Capital first reported a position in PRTA in Q1 2017 and held it in 1 quarter. The position peaked at $1.67M in Q1 2017. 145 funds tracked by Wall St. Rank hold PRTA as of Q2 2017.

Polar Capital reported no remaining Prothena Corp position as of Q2 2017 after selling out during the quarter.
Polar Capital sold 30,000 Prothena Corp shares in Q2 2017, an estimated $1.67M.
Polar Capital first reported a position in Prothena Corp in Q1 2017 and held it in 1 quarter.
Polar Capital's Prothena Corp position peaked at $1.67M in Q1 2017.
145 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2017.

Based on Polar Capital's 13F filing for Q2 2017, filed 14 Aug 2017.